Opaleye Management Inc. Quant / Systematic

Location: Boston, MA

CIK: 0001595855 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 14, 2018

Total Value: $350M (100.0% shares, 0.0% debt)

Holdings (38)

AXGN AXOGEN INC 17.9%
Value $62.6M Shares 1,715,000 Est. Cost $3.33 Unrealized +822.2%
BLUEPRINT MEDICINES 15.7%
Value $55.02M Shares 600,000 Est. Cost $27.77 Unrealized
LOXO ONCOLOGY 5.9%
Value $20.7M Shares 179,400 Est. Cost $43.63 Unrealized
CDXS CODEXIS INC 5.3%
Value $18.71M Shares 1,700,600 Est. Cost $2.93 Unrealized +227.3%
FIBROGEN INC 4.8%
Value $16.63M Shares 360,000 Est. Cost $26.18 Unrealized
STRONGBRIDGE BIOPHARMA PLC 4.0%
Value $14.07M Shares 1,590,000 Est. Cost $4.02 Unrealized
CORIUM INTERNATIONAL INC 3.5%
Value $12.21M Shares 1,065,000 Est. Cost $8.50 Unrealized
AGIO AGIOS PHARMACEUTICALS 3.0%
Value $10.63M Shares 130,000 Est. Cost $43.03 Unrealized +79.6%
FENC FENNEC PHARMACEUTICALS INC 3.0%
Value $10.56M Shares 873,000 Est. Cost $9.96 Unrealized -5.2%
SGMO SANGAMO BIOSCIENCES INC 2.9%
Value $10.16M Shares 535,000 Est. Cost $3.76 Unrealized +469.1%
CYMABAY THERAPEUTICS INC 2.5%
Value $8.638M Shares 665,000 Est. Cost $8.05 Unrealized
AMAG PHARMACEUTICALS INC 2.4%
Value $8.463M Shares 420,000 Est. Cost $20.15 Unrealized
MIRAGEN THERAPEUTICS INC 2.1%
Value $7.43M Shares 1,060,000 Est. Cost $7.01 Unrealized
DECIPHERA PHARMACEUTICALS INC 2.1%
Value $7.314M Shares 365,000 Est. Cost $20.04 Unrealized
OCULAR THERAPEUTIX INC 2.1%
Value $7.232M Shares 1,111,000 Est. Cost $6.51 Unrealized
XOMA XOMA CORP DEL 1.9%
Value $6.477M Shares 320,200 Est. Cost $6.46 Unrealized +333.2%
BIOFRONTERA AG 1.8%
Value $6.462M Shares 391,200 Est. Cost $16.52 Unrealized
ARDX ARDELYX 1.6%
Value $5.734M Shares 1,135,600 Est. Cost $7.13 Unrealized -12.5%
AUDENTES THERAPEUTICS INC 1.6%
Value $5.709M Shares 190,000 Est. Cost $22.19 Unrealized
AMARIN CORP PLC 1.5%
Value $5.252M Shares 1,745,000 Est. Cost $3.50 Unrealized
ABLYNX NV 1.4%
Value $4.91M Shares 90,000 Est. Cost $24.99 Unrealized
FOAMIX PHARMACEUTICALS LTD 1.4%
Value $4.873M Shares 950,000 Est. Cost $5.96 Unrealized
VKTX VIKING THERAPEUTICS INC 1.4%
Value $4.81M Shares 1,100,800 Est. Cost $4.39 Unrealized +26.2%
RARE ULTRAGENYX PHARMACEUTICALS INC 1.2%
Value $4.079M Shares 80,000 Est. Cost $49.03 Unrealized +2.7%
ACHILLION PHARMACEUTICALS INC 1.2%
Value $4.063M Shares 1,095,100 Est. Cost $3.38 Unrealized
DEPOMED INC 1.1%
Value $3.954M Shares 600,000 Est. Cost $6.59 Unrealized
PTCT PTC THERAPEUTICS INC 1.1%
Value $3.923M Shares 145,000 Est. Cost $25.34 Unrealized 0.0%
TGTX TG THERAPEUTICS INC 1.1%
Value $3.893M Shares 274,200 Est. Cost $12.78 Unrealized 0.0%
SNDX SYNDAX PHARMACEUTICALS INC 0.9%
Value $3.166M Shares 222,500 Est. Cost $10.61 Unrealized 0.0%
CHIMERIX INC 0.9%
Value $3.12M Shares 600,000 Est. Cost $5.07 Unrealized
QTRX QUANTERIX CORP 0.7%
Value $2.556M Shares 150,000 Est. Cost $19.82 Unrealized +1.1%
PROTALIX BIOTHERAPEUTICS INC 0.5%
Value $1.76M Shares 3,260,000 Est. Cost $0.61 Unrealized
FORTRESS BIOTECH INC 0.4%
Value $1.433M Shares 315,000 Est. Cost $4.55 Unrealized
EPIZYME INC 0.4%
Value $1.242M Shares 70,000 Est. Cost $17.74 Unrealized
SYROS PHARMACEUTICALS INC 0.3%
Value $961K Shares 74,074 Est. Cost $15.97 Unrealized
ZOSANO PHARMA CORP 0.1%
Value $504K Shares 100,000 Est. Cost $5.04 Unrealized
QUOTIENT LTD 0.1%
Value $282K Shares 60,000 Est. Cost $4.70 Unrealized
BIOLINERX LTD 0.1%
Value $214K Shares 250,000 Est. Cost $1426.15 Unrealized